Search - tctmd.com

Displaying 521 - 540 of 1176

Sort: Relevancy | Date

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Combining Frailty Index With Existing Risk Models Improves Mortality Prediction in TAVR

L.A. McKeown

February 22, 2018

News Industry News

Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark

February 20, 2018

News Daily News

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Todd Neale

February 16, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Daily News

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Michael O'Riordan

February 01, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Shelley Wood

January 05, 2018

News Daily News

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

L.A. McKeown

January 04, 2018

News Daily News

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

Caitlin E. Cox

December 21, 2017

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

News Conference News TCT 2017

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

Todd Neale

November 08, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

Advertisement

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Combining Frailty Index With Existing Risk Models Improves Mortality Prediction in TAVR

Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark

TAVR Outcomes Worse When the Right Ventricle Is Dysfunctional

Next-Generation Large-Bore Closure Devices Arrive

Surprising Rate of Cardiac Amyloidosis in TAVR Patients Poses Tough Questions for Diagnosis, Decision-Making

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Isolated Tricuspid Valve Surgery Remains Rare and Risky

More Support for TMVR After Failed Mitral Bioprostheses

A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content